Complete blood cell count
|
Blood chemistry
|
Immunologic test
|
---|
WBC
|
23,600
|
/μL
|
Albumin
|
1.5
|
g/dL
|
IgG
|
1385
|
mg/dL
|
---|
Band
|
6
|
%
|
T.Bil
|
0.4
|
mg/dL
|
IgG4
|
66
|
mg/dL
|
Seg
|
88
|
%
|
AST
|
33
|
IU/L
|
IgA
|
187
|
mg/dL
|
Lympho
|
3
|
%
|
ALT
|
12
|
IU/L
|
IgM
|
62
|
mg/dL
|
Mono
|
3
|
%
|
LDH
|
471
|
IU/L
|
ANA
|
<40
|
times
|
RBC
|
348
|
104/μL
|
γ-GTP
|
266
|
IU/L
|
anti-RNP Ab
|
–
| |
Hgb
|
9.9
|
g/dL
|
ALP
|
400
|
IU/L
|
anti-ds-DNA IgG
|
–
| |
MCV
|
86.8
|
fL
|
BUN
|
119.5
|
mg/dL
|
anti-SS-A Ab
|
–
| |
Platelet
|
7.5
|
104/μL
|
Cr
|
7.77
|
mg/dL
|
RF
|
<3
|
IU/mL
|
ESR
|
87
|
mm/hr
|
CRP
|
36.35
|
mg/dL
|
PR3-ANCA
|
<1
|
IU/mL
|
| | |
Ferritin
|
1873
|
ng/mL
|
MPO-ANCA
|
<1
|
IU/mL
|
| | |
ACE
|
7.6
|
IU/L
|
Coombs test
|
–
| |
| | |
Haptoglobin
|
311
|
mg/dL
|
PA-IgG
|
70
|
ng/107cells
|
Infectious diseases
| | | |
ADAMTS-13
|
28
|
%
|
EBV VCA IgG
|
+
| |
Coagulation system
|
anti-GBM Ab
|
<2
|
U/mL
|
EBV VCA IgM
|
-
| |
PT
|
19
|
Sec
|
sIL-2R
|
1260
|
U/mL
|
EBNA IgG
|
+
| |
PT-INR
|
1.59
| |
IL-6
|
65.1
|
pg/mL
|
CMV C7-HRP
|
-
| |
APTT
|
>80
|
Sec
|
VEGF
|
1030
|
pg/mL
|
| | |
(Standard: 26-36)
| | | | |
HIV antigen/Ab
|
-
| |
Fibrinogen
|
>600
|
mg/dL
| | | |
HHV-8 DNA (WBC106cells)
|
<20
| |
AT-III
|
58
|
%
| | | |
IGRA
|
–
| |
FDP
|
66
|
μg/mL
| | | |
- WBC White blood cell, RBC Red blood cell, Hgb Hemoglobin, MCV Mean corpuscular volume, ESR Erythrocyte sedimentation rate, EBV Epstein–Barr virus, VCA Virus capsid antigen, EBNA Epstein–Barr virus nuclear antigen, CMV Cytomegalovirus, HIV Human immunodeficiency virus, Ab Antibody, HHV-8 Human herpesvirus-8, IGRA Interferon-gamma releasing assay, T.Bil Total Bilirubin, AST Aspartate aminotransferase, ALT Alanine aminotransferase, LDH Lactate dehydrogenase, γ-GTP Gamma-glutamyl transpeptidase, ALP Alkaline phosphatase, BUN Blood urea nitrogen, Cr Creatinine, CRP C-reactive protein, ACE Angiotensin-converting enzyme, PT Prothrombin time, PT-INR Prothrombin time-international normalized ratio, APTT Activated partial thromboplastin time, AT-III Antithrombin III, FDP Fibrin/fibrinogen degradation products, ANA Antinuclear antibody, anti-RNP-antibody Anti-ribonucleoprotein antibody, anti-ds-DNA IgG Anti-double-stranded deoxyribonuclein acid immunoglobulin G, anti-SS-A antibody Anti-Sjören's syndrome A antibody, RF Rheumatoid factor, PR3-ANCA Proteinase 3-anti-neutrophil cytoplasmic antibody, MPO-ANCA Myeloperoxidase-anti-neutrophil cytoplasmic antibody, PA-IgG Platelet-associated immunoglobulin G, anti-GBM antibody Anti-glomerular basement membrane antibody, sIL-2R Soluble interleukin-2 receptor, IL-6 Interleukin-6, VEGF Vascular endothelial growth factor